Therapeutic Area | MeSH |
---|---|
skin and connective tissue diseases | D017437 |
Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Siliq | brodalumab | Bausch Health Companies | N-761032 RX | 2017-02-15 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
siliq | Biologic Licensing Application | 2024-11-07 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
psoriasis | EFO_0000676 | D011565 | L40 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Psoriasis | D011565 | EFO_0000676 | L40 | — | — | 1 | 4 | 1 | 6 |
Body weight | D001835 | EFO_0004338 | — | — | — | — | 1 | — | 1 |
Inflammation | D007249 | MP_0001845 | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Psoriatic arthritis | D015535 | EFO_0003778 | L40.5 | — | — | — | — | 1 | 1 |
Arthritis | D001168 | EFO_0005856 | M05-M14 | — | — | — | — | 1 | 1 |
Drug common name | Brodalumab |
INN | brodalumab |
Description | Brodalumab (human mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1742996 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB11776 |
UNII ID | 6ZA31Y954Z (ChemIDplus, GSRS) |